Publicacións nas que colabora con Adrián Llerena Ruiz (3)

2013

  1. Association of common genetic variants with risperidone adverse events in a Spanish schizophrenic population

    Pharmacogenomics Journal, Vol. 13, Núm. 2, pp. 197-204

  2. CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment

    Pharmacogenetics and Genomics, Vol. 23, Núm. 11, pp. 627-630

2011

  1. ATA homozigosity in the IL-10 gene promoter is a risk factor for schizophrenia in Spanish females: A case control study

    BMC Medical Genetics, Vol. 12